Claudio Majul

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients

Thomas Littlejohn, Claudio Majul, Rafael Olvera et al. · Journal of Clinical Hypertension · 2009 · 96 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Snoring, witnessed sleep apnoeas and pregnancy‐induced hypertension

Daniel Pérez-Chada, Alejandro J. Videla, Martín O’Flaherty et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2007 · 81 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Original Research: Telmisartan plus Amlodipine in Patients with Moderate or Severe Hypertension: Results from a Subgroup Analysis of a Randomized, Placebo-Controlled, Parallel-Group, 4 × 4 Factorial Study

Thomas Littlejohn, Claudio Majul, Rafael Olvera et al. · Postgraduate Medicine · 2009 · 59 citations

Medicine, Pharmacology, Pharmacotherapy +17